MVision AI, a Helsinki, Finland-based cloud-based software service provider for radiotherapy treatment planning, raised €5.4M in funding.
The round was led by J12 Ventures and Voima Ventures.
The company intends to use the funds to further accelerate cancer treatment automation and to bring the solution to more patients.
Led by Founder and CEO Mahmudul Hasan, MVision AI is a cloud-based software service provider for radiotherapy treatment planning. The AI-powered automatic segmentation tool helps users standardize contouring and automate segmentation to streamline the radiotherapy treatment planning workflow. Its learning model produces consistent contouring in minutes while maintaining the highest standards of quality for every patient, every time.
MVision AI’s technology has been used to treat more than 100,000 cancer patients in 14 countries, with most patients originating in Finland, Sweden, Spain, France, the UK and the USA.
FinSMEs
23/03/2023